Monocytic MDSC mobilization promotes tumor recurrence after liver transplantation via CXCL10/TLR4/MMP14 signaling

[1]  Erratum: Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. , 2020, CA: a cancer journal for clinicians.

[2]  A. Jemal,et al.  Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries , 2018, CA: a cancer journal for clinicians.

[3]  Tsukasa Nakamura,et al.  Myeloid-Derived Suppressor Cells as a Regulator of Immunity in Organ Transplantation , 2018, International journal of molecular sciences.

[4]  L. Rubbia‐Brandt,et al.  Effects of the gut-liver axis on ischaemia-mediated hepatocellular carcinoma recurrence in the mouse liver. , 2018, Journal of hepatology.

[5]  I. Ng,et al.  Hypoxia inducible factor HIF-1 promotes myeloid-derived suppressor cells accumulation through ENTPD2/CD39L1 in hepatocellular carcinoma , 2017, Nature Communications.

[6]  K. Man.  Recurrent malignancy: Are we pushing the envelope? , 2017, Liver transplantation : official publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society.

[7]  F. Tacke,et al.  Role of chemokine pathways in hepatobiliary cancer. , 2016, Cancer letters.

[8]  I. Ng,et al.  Hypoxia induces myeloid‐derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C‐C motif) ligand 26 , 2016, Hepatology.

[9]  R. Weichselbaum,et al.  Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome , 2015, British Journal of Cancer.

[10]  S. Fan,et al.  Alternatively activated (M2) macrophages promote tumour growth and invasiveness in hepatocellular carcinoma. , 2015, Journal of hepatology.

[11]  J. Vallée,et al.  Pre-retrieval reperfusion decreases cancer recurrence after rat ischemic liver graft transplantation. , 2014, Journal of Hepatology.

[12]  Jun Yu,et al.  Endothelial Progenitor Cell Mobilization via CXCL 10 / CXCR 3 Signaling Promotes Liver Tumor Growth , 2013 .

[13]  Alison M. Urvalek,et al.  KLF8 and FAK cooperatively enrich the active MMP14 on the cell surface required for the metastatic progression of breast cancer , 2013, Oncogene.

[14]  C. Trautwein,et al.  Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes , 2013, Hepatology.

[15]  Johnny C. Hong,et al.  Ischaemia–reperfusion injury in liver transplantation—from bench to bedside , 2013, Nature Reviews Gastroenterology &Hepatology.

[16]  S. Polyak,et al.  Molecular Pathways: Hepatitis C Virus, CXCL10, and the Inflammatory Road to Liver Cancer , 2013, Clinical Cancer Research.

[17]  Wilfrid Boireau,et al.  Chemotherapy-triggered cathepsin B release in myeloid-derived suppressor cells activates the Nlrp3 inflammasome and promotes tumor growth , 2012, Nature Medicine.

[18]  J. Llovet,et al.  Medical therapies for hepatocellular carcinoma: a critical view of the evidence , 2013, Nature Reviews Gastroenterology &Hepatology.

[19]  Johnny C. Hong,et al.  Outcomes of Living and Deceased Donor Liver Transplant Recipients With Hepatocellular Carcinoma: Results of the A2ALL Cohort † , 2012, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[20]  W. Jia,et al.  Toll-like receptor-4 mediates obesity-induced non-alcoholic steatohepatitis through activation of X-box binding protein-1 in mice , 2012, Gut.

[21]  J. Pfeilschifter,et al.  CXCL10 promotes liver fibrosis by prevention of NK cell mediated hepatic stellate cell inactivation. , 2010, Journal of autoimmunity.

[22]  S. Fan,et al.  Molecular Signature Linked to Acute Phase Injury and Tumor Invasiveness in Small-for-Size Liver Grafts , 2010, Annals of surgery.

[23]  S. Fan,et al.  Distinct Mechanism of Small‐for‐Size Fatty Liver Graft Injury—Wnt4 Signaling Activates Hepatic Stellate Cells , 2010, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[24]  D. Lopez,et al.  The liver is a site for tumor-induced myeloid-derived suppressor cell accumulation and immunosuppression. , 2009, Cancer research.

[25]  Srinivas Nagaraj,et al.  Myeloid-derived suppressor cells as regulators of the immune system , 2009, Nature Reviews Immunology.

[26]  R. Strieter,et al.  CXCL10 impairs beta cell function and viability in diabetes through TLR4 signaling. , 2009, Cell metabolism.

[27]  S. Fan,et al.  The Significance of Acute Phase Small-for-Size Graft Injury on Tumor Growth and Invasiveness After Liver Transplantation , 2008, Annals of surgery.

[28]  D. Carbone,et al.  Abrogation of TGF beta signaling in mammary carcinomas recruits Gr-1+CD11b+ myeloid cells that promote metastasis. , 2008, Cancer cell.

[29]  S. Albelda,et al.  Cross-Talk between Myeloid-Derived Suppressor Cells and Macrophages Subverts Tumor Immunity toward a Type 2 Response1 , 2007, The Journal of Immunology.

[30]  A. Lok,et al.  Hepatocellular Carcinoma Recurrence and Death Following Living and Deceased Donor Liver Transplantation , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[31]  J. Kappes,et al.  Expansion of spleen myeloid suppressor cells represses NK cell cytotoxicity in tumor-bearing host. , 2007, Blood.

[32]  B. Shalmon,et al.  CXCL10 promotes invasion-related properties in human colorectal carcinoma cells. , 2007, Cancer research.

[33]  I. Ng,et al.  Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma , 2007, The British journal of surgery.

[34]  M. Grimm,et al.  Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer. , 2006, Cancer research.

[35]  C. Divino,et al.  Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host. , 2006, Cancer research.

[36]  P. V. van Diest,et al.  Ischemia/reperfusion accelerates the outgrowth of hepatic micrometastases in a highly standardized murine model , 2005, Hepatology.

[37]  B. Fingleton,et al.  Expansion of myeloid immune suppressor Gr+CD11b+ cells in tumor-bearing host directly promotes tumor angiogenesis. , 2004, Cancer cell.

[38]  S. Fan,et al.  Graft Injury in Relation to Graft Size in Right Lobe Live Donor Liver Transplantation: A Study of Hepatic Sinusoidal Injury in Correlation With Portal Hemodynamics and Intragraft Gene Expression , 2003, Annals of surgery.

[39]  K. Man,et al.  Liver transplantation in rats using small-for-size grafts: a study of hemodynamic and morphological changes. , 2001, Archives of surgery.